WO2001000115A2 - Absorbent article made of compressed polyurethane foam - Google Patents
Absorbent article made of compressed polyurethane foam Download PDFInfo
- Publication number
- WO2001000115A2 WO2001000115A2 PCT/GB2000/002477 GB0002477W WO0100115A2 WO 2001000115 A2 WO2001000115 A2 WO 2001000115A2 GB 0002477 W GB0002477 W GB 0002477W WO 0100115 A2 WO0100115 A2 WO 0100115A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- foam
- polyurethane
- polyurethane foam
- minutes
- sample
- Prior art date
Links
- 229920005830 Polyurethane Foam Polymers 0.000 title claims abstract description 46
- 239000011496 polyurethane foam Substances 0.000 title claims abstract description 46
- 239000002250 absorbent Substances 0.000 title description 6
- 230000002745 absorbent Effects 0.000 title description 6
- 229920002635 polyurethane Polymers 0.000 claims abstract description 31
- 239000004814 polyurethane Substances 0.000 claims abstract description 31
- 238000010438 heat treatment Methods 0.000 claims description 40
- 238000012856 packing Methods 0.000 claims description 10
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 239000006260 foam Substances 0.000 description 53
- 239000000463 material Substances 0.000 description 8
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000005299 abrasion Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000009429 electrical wiring Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 229940124326 anaesthetic agent Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- HIDUXZXZQUHSBT-UHFFFAOYSA-N ethenol;formaldehyde Chemical compound O=C.OC=C HIDUXZXZQUHSBT-UHFFFAOYSA-N 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- 229940072358 xylocaine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2051—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the material or the structure of the inner absorbing core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2051—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the material or the structure of the inner absorbing core
- A61F13/2057—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the material or the structure of the inner absorbing core made of foam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2082—Apparatus or processes of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2082—Apparatus or processes of manufacturing
- A61F13/2085—Catamenial tampons
- A61F13/2088—Catamenial tampons shaping the tampon by compressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/36—Surgical swabs, e.g. for absorbency or packing body cavities during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00731—Plasters means for wound humidity control with absorbing pads
- A61F2013/0074—Plasters means for wound humidity control with absorbing pads containing foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
Definitions
- the present invention relates to absorbent devices especially absorbent devices for woundcare and feminine hygiene.
- the present invention also relates to packing devices especially surgical packing devices.
- Sponges and other packing materials used for woundcare and feminine hygiene devices require a high degree of absorptivity. Having a device with a high level of absorptivity is particularly important for surgery of the nose, or nasal haemorrhages in general, since there are branches of several arteries located quite close to the surfaces of the nasal septum and other areas of the nasal cavity.
- gauze packs There are a number of materials and devices commonly used for such woundcare, surgery and feminine situations.
- One commonly used type of material is gauze packs; however, gauze packs have many disadvantages and are known to cause damage to body tissue, for example, nasal lining, during insertion and removal. As the gauze packs absorb blood and other blood fluids, they become progressively less pliable (and stiffer), thus tending to continue the undesirable abrasive effect.
- hydroxylated polyvinyl acetal foams also known by the names of PVAc foams, polyvinyl formal foams and PVA foams.
- PVAc foams polyvinyl formal foams
- PVA foams polyvinyl formal foams
- MEROCEL trade Name MEROCEL
- PVAc foams can be crushed to aid insertion through small orifices and are therefore useful in endoscopic procedures. Being a foam they do not shed fibres; however when in the crushed and dehydrated state, the foam is hard, which may cause tissue abrasion on insertion. There is also a tendency for the foam to absorb at too high a rate causing swelling during insertion and leading to complications. Adhesion to the wound surface has been a problem in the past resulting in pain on removal and further damage to the tissue.
- Soft absorbent polyurethane foams are also used for surgery in sensitive areas, for example, in nasal procedures, to reduce the effects of abrasion seen when other materials are used.
- these polyurethane foams cannot be preshaped by crushing, like the PVAc foams.
- the present invention is based on the discovery that by crushing a polyurethane foam to the desired shape and heating the polyurethane foam at an elevated temperature for a relatively short period of time, that on cooling, the polyurethane foam is found to substantially retain its crushed shape but is still substantially soft and pliable.
- a polyurethane device obtainable by crushing a polyurethane foam to a desired shape and heating the crushed polyurethane foam at an elevated temperature.
- a shaped polyurethane device produced by the method of crushing a polyurethane foam sample to a desired shape and heating the crushed polyurethane foam at an elevated temperature for a pre-set period of time to set the device in the desired shape.
- a method of manufacturing a polyurethane device comprising the step of; crushing a polyurethane foam to a desired shape and heating the crushed polyurethane foam at an elevated temperature.
- One embodiment of above include where the polyurethane foam is heated whilst it is being crushed.
- a shaped polyurethane device produced by the method of crushing a polyurethane foam sample to a desired shape and heating the crushed polyurethane foam at an elevated temperature for a pre-set period of time for absorption of fluids.
- the invention will work for any type of polyurethane foam and this may be linear-chain polyurethane foam.
- the foams will be hydrophilic and flexible.
- the polyurethane foams may be polyester and/or polyether polyurethanes, (inter alia).
- the polyurethane foam can be crushed to almost any predetermined shape, or configuration, required, thus having considerable advantage for different dressing types required for easy insertion to wound, nasal, sinus or ear cavities.
- the pressure, temperature and time period for the heating process to heat the crushed polyurethane foam whilst it is in its desired shape is any pressure, temperature, and duration, such that when on cooling the foam, the foam will substantially retain its shape.
- Suitable pressures, temperatures and durations for the heating process will depend on the size of the polyurethane samples as larger samples may require more heating. Likewise the pressure, temperature and duration time are related and dependent on each other. When a higher heating temperature is used in the heating process a shorter duration time may be required than when a lower heating temperature is used. Also when a high pressure is used during the heating process, the heating temperature and time period for the heating process may be less than when a low pressure is used during the heating process.
- the type of polyurethane foam, the shape of the foam and the means of crushing the foam may all affect the required temperature and duration of the heating process.
- the physical pressure on the crushed foam may also effect the requirements for the heating process.
- suitable temperature ranges for heating the polyurethane foam may be between 45°C and 200°C, or 45°C and 95°C, or between 45°C and 85°C, or between 50°C and 75°C, or between 60°C and 75°C.
- the temperature for the heating of the polyurethane foam will be greater than 50°C and more preferably greater than 55°C. It is envisaged that for many smaller polyurethane foam samples being heated that a temperature of around 70°C will be a suitable temperature for the heating process.
- the heating process may range from a few seconds to several hours. Suitable durations for the heating process may be between 1 second and 7 hours, or between 2 seconds and 4 hours, or between 5 minutes and 120 minutes, but preferable the time period for the heating process will be less than 120 minutes and more preferably less than 60 minutes. Suitable durations for the heating process are between 5 minutes and 50 minutes, or 5 minutes and 40 minutes or 5 minutes and 30 minutes. Suitably the duration of the heating process may be around 10 minutes.
- the heating process at atmospheric pressure, may have a heating temperature between 50°C and 80°C for around 15 minutes, or between 60°C and 75°C for around 12 minutes, or between 65°C and 75°C for around 10 minutes.
- the heating process will have a temperature greater than 30°C and a duration less than 25 minutes.
- the heating process will have a temperature of around 70°C and a heating duration of around 10 minutes.
- the heating process will have a temperature of 100°C and a heating duration of 5 minutes.
- Other heating processes regarding temperatures, pressure and time can be readily ascertained by the skilled person without undue experimental burden.
- any means to cut and shape the polyurethane foam before the heating process may be used to shape the foam to the required configuration.
- the foam may be pushed or pulled into hollow body of the desired shape.
- this container may be a tube.
- the polyurethane foam may be crushed and then cut to the desired shape before use.
- the cooling mechanism of the heat treated polyurethane foam may be any known cooling mechanism. This may include flash cooling.
- the polyurethane foam may have one or more film layers attached to one or more of its surfaces.
- These films may include polyurethane films but any suitable film attached to the polyurethane foam may be used.
- Suitable films include any flexible polymer including flexible block co-polymers.
- the film is elastomeric.
- the film may also contain perforations to aid fluid absorption.
- the film may also be non-adhering.
- the foam of the present invention may act as a carrier for active agents.
- active agents it is meant pharmacological active agents and agents including topical anaesthetics such as amethocaine, xylocaine; bacteriostatic agents such as silver nitrate; antibacterial agents of which preferred agents include silver sulphadiazine, chlorohexidine salts, PVP-1 , and biguanides antibiotics; topical steroids, enzyme stimulants, coagulants and anticoagulants and antifungal agents.
- Figure 1 shows a sample of a polyurethane foam before crushing.
- Figure 2 shows the foam of Figure 1 partially inserted into a tube.
- Figure 3 shows the polyurethane foam of Figure 1 inserted fully into the tube.
- Figure 4 shows a polyurethane foam suitably shaped for use as an ear wick.
- Figure 5 shows a polyurethane foam suitably shaped for use as a fenestrated ear wick.
- Figure 6 shows a polyurethane foam suitably shaped for use as an ear pack.
- Figure 1 there is shown a polyurethane foam (1 ) with a 1 mm diameter hole (2) cut through it in order to enable the polyurethane foam to be pulled through a tube when a surgical suture (3), or the like, is threaded through the hole.
- FIG. 2 there is shown the foam (1 ) partially inserted into a transparent tube (4) as the suture, or thread, is pulled through the tube.
- Figure 3 shows the polyurethane foam (1 ) completely inserted into a transparent tube (4) ready for the heating process.
- a polyurethane sample measuring approximately 17mm wide and 35mm long was cut from a commercially available (polyurethane) ALLEVYNTM dressing.
- a 1 mm diameter hole was cut into the polyurethane sample and a surgical suture, of approximately 10cm long was threaded through the hole.
- the polyurethane sample was pulled, with the aid of the surgical suture, into a 1 ml syringe.
- the internal diameter of the syringe is approximately 5mm.
- the syringe together with the polyurethane sample was then heated in an oven at 70°C for approximately 10 minutes. After heating in the oven the syringe containing the polyurethane sample was removed from the oven and allowed to cool at room temperature. Once cool, the compressed foam was removed from the tube and it substantially retained its compressed shape.
- the cut sample was placed into a heat shrinkable tubing (initial internal diameter 6mm).
- the heat shrinkable tubing is generally used in electrical wiring.
- the heat shrinkable tubing has a theoretical shrink ratio of 3:1 (i.e. should shrink to 2mm ID). Resistance from the foam limited the shrink to 4mm (i.e. ratio of 3:2).
- the heat shrinkable tubing shrinks evenly in diameter, producing a uniform compression, which produces a well-shaped sample that expands uniformly (i.e. at fairly constant rate at all points of the compressed item) on hydration.
- the sleeve with cut sample was placed in a fan assisted oven at 120°C for 2 minutes, then to 'set' the foam, the sleeve and foam were then transferred to another fan assisted oven, set at 85°C, for a further 10 minutes.
- the sleeve containing the polyurethane sample was removed from the oven and allowed to cool at room temperature. Once cool the compressed foam was removed from the sleeve.
- the compressed foam substantially retained its compressed shaped and was also substantially soft and pliable. Such foams of this shape may suitably be used as Ear Wicks.
- the final crushed shape was approximately 4mm in diameter and 13mm in length.
- a polyurethane sample as described in Example 2 was placed into a heat shrinkable tubing (initial internal diameter 6mm).
- the heat shrinkable tubing had a theoretical shrink ratio of 3:1 (i.e. should shrink to 2mm ID).
- To shrink the sleeve the sleeve with cut sample was placed in a fan-assisted oven set at 120°C for 2 minutes.
- the sleeve containing the cut sample was then placed into another heat shrinkable tubing (initial ID 4.8mm, shrink ratio 2:1 ). This was then placed in another fan-assisted oven, set at 85°C, for a further 10 minutes.
- the sleeve containing the polyurethane sample was removed from the oven and allowed to cool at room temperature. Once cool, the compressed foam was removed from the sleeve. The compressed foam substantially retained its compressed shape and was also substantially soft and pliable. The final crushed sample was approximately 3mm in diameter and 13mm in length.
- a polyurethane sample shaped as shown in Figure 5 was cut from a commercially available (polyurethane) ALLEVYNTM dressing.
- the precrushed dimensions of the cut polyurethane were 7mm external diameter, 11.5mm in length and the central hole had a diameter of 4.6mm. Foam of this shape once treated may suitably be used as Fenestrated Ear Wicks.
- the cut sample was placed into a heat shrinkable tubing (initial internal diameter 6mm).
- the heat shrinkable tubing is generally used in electrical wiring.
- the heat shrinkable tubing has a theoretical shrink ratio of 3:1 (i.e. should shrink to 2mm ID). Resistance from the foam limited the shrink to 4mm (i.e. ratio of 3:2).
- the heat shrinkable tubing shrinks evenly in diameter, producing a uniform compression, which produces a well-shaped sample that expands uniformly (i.e. at fairly constant rate at all points of the compressed item) on hydration.
- the sleeve with cut sample was placed in a fan assisted oven at 120°C for 2 minutes, then to 'set' the foam, the sleeve and foam were then transferred to another fan assisted oven, set at 85°C, for a further 10 minutes.
- the sleeve containing the polyurethane sample was removed from the oven and allowed to cool at room temperature. Once cool the compressed foam was removed from the sleeve. The compressed foam substantially retained its compressed shaped and was also substantially soft and pliable. The final crushed shape was approximately 3.5mm in external diameter, 13mm in length and the internal hole having a diameter of 1 mm.
- the cut sample was placed into a heat shrinkable tubing (initial internal diameter 6mm).
- the heat shrinkable tubing had a theoretical shrink ratio of 3:1 (i.e. should shrink to 2mm ID).
- To shrink the sleeve the sleeve with cut sample was placed in a fan-assisted oven set at 120°C for 2 minutes.
- the sleeve containing a sample was then placed into another heat shrinkable tubing (initial ID 4.8mm, shrink ratio 2:1 ). This was then placed in another fan-assisted oven, set at 85°C, for a further 10 minutes.
- the sleeve containing the polyurethane sample was removed from the oven and allowed to cool at room temperature. Once cool, the compressed foam was removed from the sleeve. Again the compressed sample substantially retained its compressed shape, having approximately an external diameter of 2mm and a length of 13mm. The compressed sample was also substantially soft and pliable.
- a cylinder of hydrophilic foam (diameter: 15mm; length: 20mm) was tightly wrapped with a length of a perforated polyurethane wound contact layer (wcl).
- the wrapped foam was placed between two sheets of s siliconised release paper, and passed 'sideway' (longest dimension parallel to the laminating roller axis) through a heated laminating unit (Laminex International Ltd., model DTL A4).
- the laminator had an operating temperature of 150°C and the wrapped foam was passed through the laminator at a speed of 0.67m/min. Even though the wcl was tightly wrapped around the foam, doe to the compression of the foam, there was always a 'flange' of wcl on the leading and trailing edges. In order to obtain a neat finish and improve lamination, the excess material was trimmed to ⁇ 2mm and wrapped around the foam.
- the foam cylinder was turned through 90 degrees on its long axis and passed through the laminator again.
- the sample was placed in the centre of a length of plastic braid material.
- the nominal diameter of the plastic braid material was 5mm, though it was expanded to around 15mm diameter to envelop the pack.
- the braid was then pulled into a plastic tube, a pipette body (internal diameter 8mm) to compress the cut sample foam.
- the whole assembly was 'cooked' in a fan assisted oven at 85°C for 5 minutes to achieve a temporary 'set'. 10 minutes after removing from the oven the compressed foam was removed from the tube/braid, and placed into a length of heat shrinkable tubing. To shrink the sleeve, the sleeve with foam pack was placed in a fan-assisted oven set at 120°C for 2 minutes. To 'set' the foam, the sleeve and foam were then transferred to another fan-assisted oven, set at 85°C, for a further 5 minutes.
- the compressed foam was removed from the sleeve.
- the foam substantially retained its compressed shape having approximately a length of 23mm and an external diameter of 7.5mm.
- the compressed foam was also substantially soft and pliable.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Manufacturing & Machinery (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
- Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU55548/00A AU5554800A (en) | 1999-06-29 | 2000-06-28 | Absorbent device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9915088.0A GB9915088D0 (en) | 1999-06-29 | 1999-06-29 | Absorbent device |
GB9915088.0 | 1999-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001000115A2 true WO2001000115A2 (en) | 2001-01-04 |
WO2001000115A3 WO2001000115A3 (en) | 2001-05-25 |
Family
ID=10856200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/002477 WO2001000115A2 (en) | 1999-06-29 | 2000-06-28 | Absorbent article made of compressed polyurethane foam |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5554800A (en) |
GB (1) | GB9915088D0 (en) |
WO (1) | WO2001000115A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2159255A1 (en) | 2008-08-27 | 2010-03-03 | Bayer MaterialScience AG | Method for producing formed polyurethane foam wound dressing |
EP2158924A1 (en) | 2008-08-27 | 2010-03-03 | Bayer MaterialScience AG | Method for producing formed polyurethane foam wound dressing |
EP2345431A2 (en) | 2002-06-11 | 2011-07-20 | Basf Se | Method for producing esters from polyalcohols |
US20220142825A1 (en) * | 2020-11-12 | 2022-05-12 | Chen Chi Hsiang Industry Limited | Tampon and pad body having a foam absorbent body |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3709966A (en) * | 1969-01-30 | 1973-01-09 | Olin Corp | Compression of layers of polyurethane foam containing at least alternate layers of partially cured foam |
US3961629A (en) * | 1968-06-11 | 1976-06-08 | American Cyanamid Company | Using hydrophilic polyurethane laparotomy sponges |
US3978266A (en) * | 1972-10-05 | 1976-08-31 | Ionics Lyo Products Company | Surgical dressings |
WO1999002587A1 (en) * | 1997-07-09 | 1999-01-21 | Huntsman Ici Chemicals Llc | Compressed hydrophilic polyurethane foams |
-
1999
- 1999-06-29 GB GBGB9915088.0A patent/GB9915088D0/en not_active Ceased
-
2000
- 2000-06-28 WO PCT/GB2000/002477 patent/WO2001000115A2/en active Application Filing
- 2000-06-28 AU AU55548/00A patent/AU5554800A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3961629A (en) * | 1968-06-11 | 1976-06-08 | American Cyanamid Company | Using hydrophilic polyurethane laparotomy sponges |
US3709966A (en) * | 1969-01-30 | 1973-01-09 | Olin Corp | Compression of layers of polyurethane foam containing at least alternate layers of partially cured foam |
US3978266A (en) * | 1972-10-05 | 1976-08-31 | Ionics Lyo Products Company | Surgical dressings |
WO1999002587A1 (en) * | 1997-07-09 | 1999-01-21 | Huntsman Ici Chemicals Llc | Compressed hydrophilic polyurethane foams |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2345431A2 (en) | 2002-06-11 | 2011-07-20 | Basf Se | Method for producing esters from polyalcohols |
EP2345432A2 (en) | 2002-06-11 | 2011-07-20 | Basf Se | Method for producing esters from polyalcohols |
EP2159255A1 (en) | 2008-08-27 | 2010-03-03 | Bayer MaterialScience AG | Method for producing formed polyurethane foam wound dressing |
EP2158924A1 (en) | 2008-08-27 | 2010-03-03 | Bayer MaterialScience AG | Method for producing formed polyurethane foam wound dressing |
US20220142825A1 (en) * | 2020-11-12 | 2022-05-12 | Chen Chi Hsiang Industry Limited | Tampon and pad body having a foam absorbent body |
Also Published As
Publication number | Publication date |
---|---|
AU5554800A (en) | 2001-01-31 |
WO2001000115A3 (en) | 2001-05-25 |
GB9915088D0 (en) | 1999-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2080497C (en) | Hydrogel gauze | |
US5423736A (en) | Wound dressing with dehydrated hydrogel gauze | |
US5115801A (en) | Hydrogel burn dressing product | |
US6191335B1 (en) | Dressings | |
US4159719A (en) | Moisture-expandable ear wick | |
US9302033B2 (en) | Wound treatment device with elastically deformable vacuum producing element | |
EP2079489B1 (en) | Absorbent structure in an absorbent article | |
US5336163A (en) | Expandable nasal stent | |
US4096230A (en) | Method of fabricating a moisture-expandable prosthesis | |
CA2185070C (en) | Nasal stent | |
US20080103462A1 (en) | Wound healing patch with integral passive vacuum and electrostimulation | |
AU2009251810B2 (en) | Negative pressure wound therapy device | |
US5762620A (en) | Wound dressing containing a partially dehydrated hydrogel | |
WO2019113091A1 (en) | Wound dressing with negative pressure retaining valve | |
JPH0798051B2 (en) | Roll-shaped wound protection material | |
JPH06233810A (en) | Columnar wound treatment article for deep wound | |
US20100049166A1 (en) | Medical product for treatment of sinusitis | |
JPS5825461B2 (en) | Oukiyuuteateyou Houtai | |
WO2006005939A1 (en) | Vacuum wound dressings | |
EP2394677B1 (en) | Medical product, in particular for removing body liquids from human and/or animal body cavities | |
JP4171108B2 (en) | Skin patch and method for producing the same | |
GB2376632A (en) | Removable cavity wound dressings | |
WO2001000115A2 (en) | Absorbent article made of compressed polyurethane foam | |
KR102008591B1 (en) | Adhesive plaster structure for treating wounds caused by ingrown nails | |
EP0650713B1 (en) | Wound packing and package therefore |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |